4 most recent filings and news items mentioning ONCY. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/ONCY/news?limit=20"
Pull ONCY filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayOncolytics Biotech announced a newly issued USPTO patent protecting its proprietary manufacturing process for pelareorep, providing intellectual property protection until 2044. The patent strengthens the company's ability to produce pelareorep at commercial scale while supporting
View filing at SEC.gov →Oncolytics Biotech appointed Steve Glover, former Ambrx chairman, to its board of directors and promoted John McAdory to Chief Operating Officer to oversee clinical operations and business development. The moves signal organizational strengthening as the company advances pelareor
View filing at SEC.gov →Oncolytics Biotech announced initial preclinical findings showing pelareorep demonstrated greater anti-tumor activity in combination with RAS-targeted approaches compared to individual treatments in solid tumor models. The company plans additional studies in pancreatic and colore
View filing at SEC.gov →Oncolytics Biotech announced translational data from GOBLET and AWARE-1 trials will be presented at ASCO 2026, demonstrating pelareorep's immune activation mechanisms in gastrointestinal tumors. The data showing expansion of tumor-specific T cells and correlation with tumor regre
View filing at SEC.gov →